Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Francesco PattiClara Grazia ChisariClaudio SolaroMaria Donata BenedettiEliana BerraAssunta BiancoRoberto Bruno BossioFabio ButtariLetizia CastelliPaola CavallaRaffaella CerquaGianfranco CostantinoClaudio GasperiniAngelica GuareschiDomenico IppolitoRoberta LanzilloGiorgia Teresa ManiscalcoManuela MattaDamiano PaolicelliLoredana PetrucciSimona PontecorvoIsabella RighiniMargherita RussoFrancesco SaccàGiovanna SalamoneElisabetta SignorielloGabriella SpinicciDaniele SpitaleriEleonora TavazziMaria TrottaMauro ZaffaroniMario Zappianull nullPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
Our study confirmed that the therapeutic benefit of cannabinoids may extend beyond spasticity, improving spasticity-related symptoms even in non-NRS responder patients.